SZLS And their Planshey all,
I like to think that everyone here knows that this is a huge week for SZLS, and the next month will be even more important in regards to hitting milestones and showing what this company is bringing to the table.
Seeing the daily onslaught of bashing is reminding me of before they released the bomb about making millions and expecting Massive growth.
That being said, I would like to pull out a couple points from the Prospectus, to remind everyone SZLS plans and milestones that we are going to be hearing about very soon.
first off, here is a link to the prospectus
javascript:submitFiling(document.form1600087252400,'AcceptTermsOfUse');
If that does not work google "SZLS sedar" and end up here.
https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00009903
look for June 1st "
Preliminary short form prospectus - English" that is the copy of the prospectus which explains in great detail their plans.
now for some Meat and Potatoes
| Objective | Milestones | Timing | Remaining Cost |
| Maximize U.S. testing capabilities with staff and equipment to 1,000 COVID-19 Tests per day | Fully staffed lab with validated equipment; capable of processing 1,000 COVID-19 Tests/day | Current | $2,200,000 (to be funded by cash on hand and proceeds of the Offering) |
| Increase COVID-19 Tests capability above 1,000 tests per day | Increase laboratory staff by five (5) or nine (9) fulltime employees (under the Minimum Offering and Maximum Offering scenarios, respectively). Purchase additional equipment and supplies | Aug-20 | $700,000 to $2,500,000 (to be funded by cash on hand and proceeds of the Offering) |
| Advance Aristotle® to commercialization | Complete CAP validation. Additional equipment brought online. Purchase additional supplies | Six (6) months | $50,000 to $575,000 (to be funded by cash on hand and proceeds of the Offering) |
| Expand marketing to drive adoption of Aristotle® | Develop patient-initiated SEO platform | Six (6) months | $300,000 (to be funded by proceeds of the Offering) |
I Have highlighted a very important row of information.
Thanks to Sag, and a lot of other vets here, who have been keeping us posted with the New Positions added updates, we know that SZLS is now in this stage.
Every one knows here, that SZLS has been knocking milestones off from this prospectus to a TEE, which makes me believe this is no different.
At this point in their plan, which was backed by some very smart institutional investors, researched and advised on by Clarus, we can confidently expect to be at this point
- at 1000 tests per day, if not getting above that number very soon.
- 3 months into the 6 months timing required to reach the next 2 milestones of advancing ARISTOTLE to comercialization, as well as expanding marketing to drive adoption of ARISTOTLE.
To sum it all up.
Split or no split, news or no news, this is where this company stands.
We are making Millions a month when our cash burn rate is around $300,000 a month, as mentioned on page 22/44.
"This expectation is based on the assumption that StageZero’s operating non-development cash burn remains at approximately $300,000 per month going forward, and there are minimal additional unplanned or unforeseen expenses that are incurred during this period, and does not account for proceeds from additional warrant exercises, if any. However, this is forward-looking information. Actual results may vary from the forward-looking information and risk factors could cause actual results to differ materially from the forward-looking information. See “Forward-Looking Information” and “Risk Factors”
This is extremely important.
They are burning $300,000 and making +1,000,000 per month
= +$700,000 per month positive cash flow.
When SZLS Says they are planning to list on the Nasdaq and thats the reason for the split, then i believe that their inside knowledge of what their product is going to achieve, we will no doubt be there.
.08c cents to .50c
.50c to $4.00
makes no difference. we are looking at making a lot of money
hold patient.
Cheers,
Bully